Filippatos, G., Butler, J., Farmakis, D., Zannad, F., Ofstad, A. P., Ferreira, J. P., . . . Anker, S. D. (2022). Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes. Circulation, 146(9), . https://doi.org/10.1161/CIRCULATIONAHA.122.059785
Chicago-Zitierstil (17. Ausg.)Filippatos, Gerasimos, et al. "Empagliflozin for Heart Failure with Preserved Left Ventricular Ejection Fraction with and Without Diabetes." Circulation 146, no. 9 (2022). https://doi.org/10.1161/CIRCULATIONAHA.122.059785.
MLA-Zitierstil (9. Ausg.)Filippatos, Gerasimos, et al. "Empagliflozin for Heart Failure with Preserved Left Ventricular Ejection Fraction with and Without Diabetes." Circulation, vol. 146, no. 9, 2022, https://doi.org/10.1161/CIRCULATIONAHA.122.059785.